Thomas P. McDonnell, Chief Commercial Officer at Neos Therapeutics, Inc. (NEOS), bought 3,000 shares at $7.56 ($23K) on 2016-05-19, disclosed to the SEC on 2016-05-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.